Aminotetralin drugs and D3 receptor functions: What may partially selective D3 receptor ligands tell us about dopamine D3 receptor functions?

Biochemical Pharmacology

Volumn 52, Issue 4, 1996, Pages 511-518

  Lévesque, Daniel ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

7 OH DPAT; Aminotetralin; Autoreceptor; Cocaine; Dopamine D2 receptor; Dopamine D3 receptor; Locomotion; Rat

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; DOPAMINE 3 RECEPTOR; RECEPTOR SUBTYPE; TETRALIN DERIVATIVE; AUTORECEPTOR; DOPAMINE; DOPAMINE RECEPTOR;

BRAIN; DRUG ABUSE; DRUG RECEPTOR BINDING; HUMAN; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BINDING COMPETITION; CEREBELLUM; DRUG EFFECT; PHYSIOLOGY;

ANIMALS; AUTORECEPTORS; BINDING, COMPETITIVE; CEREBELLUM; DOPAMINE; RECEPTORS, DOPAMINE;

EID: 0029666093     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00239-0     Document Type: Note

References (42)

1. 3) as a target for neuroleptics. Nature 347: 146-151, 1990.
2. 3 receptors in rat brain. Eur J Pharmacol 211: 189-194, 1992.
3. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89: 8155-8159, 1992.
4. 3 dopamine receptor: Pharmacologic properties and development of antibodies. J Pharmacol Exp Ther 264: 1002-1011, 1993.
5. Feenstra MGP, Sumners C, Goedemoed JH, De Vries JB, Rollema H and Horn AS, A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity. Naunyn Schmiedebergs Arch Pharmacol 324: 108-115, 1983.
6. 1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum. Mol Pharmacol 26: 452-457, 1984.
7. Wikström H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-E, Johansson AM, Nilsson JLG, Svensson K, Hjorth S and Carlsson A, Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: Structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine receptor agonists. J Med Chem 28: 215-225, 1985.
8. El Mestikawi S, Glowinski J and Hamon M, Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals. J Neurochem 46: 12-22, 1986.
9. Mulder TBA, De Vries JB, Dijkstra D, Wiechers JW, Grol CJ and Horn AS, Further in vivo and in vitro studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin. Naunyn Schmiedebergs Arch Pharmacol 336: 494-501, 1987.
10. 3 receptors. Eur J Pharmacol 272: R1-R3, 1995.
11. 3 receptors in vivo. Eur J Pharmacol 218: 373-375, 1992.
12. 3 receptors in the islands of Calleja of the rat using quantitative receptor autoradiography. Eur J Pharmacol 261: 179-183, 1994.
13. 3 receptor binding by N-ethylmaleimide and neurotensin. Brain Res 643: 343-348, 1994.
14. 125I]-iodosulpride. Synapse 19: 1-13, 1995.
15. 3 dopamine receptors in the rat brain. J Pharmacol Exp Ther 274: 1558-1565, 1995.
16. 3H]propyl-2-aminotetralin and carbetapentane. J Neurochem 64: 700-710, 1995.
17. 3 receptors determined with EEDQ. Soc Neurosci Abstr 20(Part 1): 526, 1994.
18. 3 receptors and σ sites in the bovine caudate nucleus. Eur J Pharmacol 242: R1-R2, 1993.
19. 3H]-(+)-Pentazocine binding to sigma recognition sites in human cerebellum. Life Sci 55: PL389-PL395, 1994.
20. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res 648: 222-228, 1994.
21. 3 dopamine receptors to G-proteins. FEBS Lett 315: 223-226, 1993.
22. 2 dopamine receptors. Mol Pharmacol 45: 51-60, 1994.
23. 3 dopamine receptor. J Pharmacol Exp Ther 268: 417-426, 1994.
24. 3 receptor expressed in transfected cell lines. Eur J Pharmacol 266: 79-85, 1994.
25. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268: 495-502, 1994.
26. 2 receptor. Eur J Pharmacol 225: 331-337, 1992.
27. 3 dopamine receptors in GH4C1 pituitary cells. FEBS Lett 312: 123-126, 1992.
28. 3 receptor in a transfected NG108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol 268: 129-139, 1994.
29. 3 dopamine receptors. J Neurosci 14: 1463-1476, 1994.
30. 3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br J Pharmacol 111: 391-393, 1994.
31. 3 receptor ligand, (+)-UH232, is a partial agonist. Eur J Pharmacol 282: R3-R4, 1995.
32. 4 dopamine receptors in HEK293 cells. J Recept Signal Transduct Res 15: 267-281, 1995.
33. 3 receptors stably transfected in HEK-293 cells. Soc Neurosci Abstr 21 (Part 1): 624, 1995.
34. 2 receptors. Neuroreport 6: 329-332, 1995.
35. Lefkowitz RJ, Cotecchia S, Samama P and Costa T, Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14: 303-307, 1993.
36. Ren Q, Kurose H, Lefkowitz RJ and Cotecchia S, Constitutively active mutants of the α2-adrenergic receptor (published erratum appears in J Biol Chem 269: 1566, 1994). J Biol Chem 268: 16483-16487, 1993.
37. 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91: 2699-2702, 1994.
38. 1B receptor subtype. J Biol Chem 269: 27925-27931, 1994.
39. 2-like dopamine receptors in rat brain. J Pharmacol Exp Ther 262: 929-935, 1992.
40. 3H]quinpirole binding sites in the rat brain. Synapse 14: 113-120, 1993.
41. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J Pharmacol Exp Ther 264: 991-1001, 1993.
42. 3 receptors: Effects of ions and guanine nucleotides. J Pharmacol Exp Ther 274: 790-797, 1995.